Genzyme's Seprafilm recommended for US approval
This article was originally published in Clinica
Executive Summary
Genzyme's bioresorbable membrane, Seprafilm, has been recommended for US FDA approval by the agency's advisory General and Plastic Surgery Devices Panel. The Massachusetts- based company's coating solution, Sepracoat, designed to complement Seprafilm, is also undergoing expedited FDA review.